Literature DB >> 16857455

Cryoablation of small peripheral renal masses: a retrospective analysis.

Bradley F Schwartz1, John C Rewcastle, Timothy Powell, Christopher Whelan, Ted Manny, J Clifton Vestal.   

Abstract

Renal cryoablation is a minimally invasive, nephron-sparing option that has shown promise in the treatment of patients with solitary small renal lesions suspicious for malignancy. Few large clinical studies have used this promising technology, although intermediate-term data are encouraging. We present a retrospective review and report the outcomes of a large cohort of patients who underwent renal cryotherapy. Patients who were candidates for partial nephrectomy with peripheral lesions < or = 5.0 cm in maximum diameter and no history of bleeding disorders were offered cryoablation as definitive therapy. Two freeze-thaw cycles were used for all lesions, and all were characterized by intraoperative ultrasound immediately before freezing. Data were collected as part of standard care, and chart review was performed only in cases of missing data. From February 2001 to March 2005, 85 consecutive patients with an average age of 67 years and a mean tumor size of 2.6 cm (range, 1.2-4.7 cm; median, 2.5 cm), underwent renal cryoablation; 70 procedures were performed laparoscopically. Mean estimated blood loss was 58 mL, with 2 patients requiring transfusion. Mean hospital stay was 3.0 days (range, 0-14 days; median, 2 days) for the entire cohort and 2.2 days (range, 0-7 days; median, 2 days) for the laparoscopic group. A total of 7 laparoscopic cases were converted to an open approach early in the experience, 2 of which were considered technical failures. Mean follow-up was 10 months (range, 3-36 months). Abnormal postoperative enhancement occurred in 2 patients at 3 months and 12 months. Radical nephrectomy in the first revealed no viable tumor; needle biopsy in the second revealed renal cell carcinoma, which prompted nephrectomy. Intraoperative needle biopsy yielded a 59% malignancy rate. We conclude that renal cryotherapy is a viable option for nephron-sparing surgery in small, peripheral renal lesions. The procedure is well tolerated, may be considered in patients who are not good candidates for open surgical approaches, results in minimal morbidity, and has shown encouraging treatment results. Close posttreatment surveillance is essential. Longer-term follow-up data will be necessary if the long-term durability of renal cryotherapy is to be established.

Entities:  

Mesh:

Year:  2006        PMID: 16857455     DOI: 10.1016/j.urology.2006.03.067

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  Cell death along single microfluidic channel after freeze-thaw treatments.

Authors:  Yuhui Li; Fen Wang; Hao Wang
Journal:  Biomicrofluidics       Date:  2010-03-25       Impact factor: 2.800

2.  Thermoablation of Renal Masses: The Urologist's Perspective.

Authors:  Phillip H Abbosh; Sam B Bhayani
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

Review 3.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

4.  Ablative therapies for renal tumors.

Authors:  Rajan Ramanathan; Raymond J Leveillee
Journal:  Ther Adv Urol       Date:  2010-04

5.  Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.

Authors:  David A Kunkle; Robert G Uzzo
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

6.  The impact of renal tumor size on the efficacy of laparoscopic renal cryoablation.

Authors:  Byeong Kuk Ham; Sung Gu Kang; Hoon Choi; Young Hwii Ko; Seok Ho Kang; Jun Cheon
Journal:  Korean J Urol       Date:  2010-03-19

7.  Review of the efficacy and safety of cryoablation for the treatment of small renal masses.

Authors:  Anil Kapoor; Naji J Touma; Regina El Dib
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

8.  The role of pathology in small renal mass laparoscopic cryoablation.

Authors:  B W Lagerveld; H van Dekken; G J L H van Leenders; J A van der Zee
Journal:  Adv Urol       Date:  2012-03-19

9.  Current status of ablative therapies for renal tumors.

Authors:  Adam C Mues; Jaime Landman
Journal:  Indian J Urol       Date:  2009 Oct-Dec

Review 10.  [Interventional oncology in urology].

Authors:  J Tacke
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.